Abstract
ABSTRACT: This study was designed to examine β-nerve growth factor (NGF) levels in human cord blood by a two-site enzyme immunoassay using MAb 27/21 to mouse NGF and to determine whether β-NGF levels show developmental changes. Blood was collected at delivery from 61 newborns, 55 neonates appropriate for gestational age (46 term infants and 9 premature infants), 5 neonates small for gestational age, and 1 neonate with congenital hydrocephalus. In addition, samples were collected from 2 microcephalic children (microcephaly vera) aged 15 and 18 mo, 2 control children, and 4 healthy adults. Mean levels of NGF in preterm infants (n = 9; 13.7 ± 8 pg/mL) were significantly lower than levels in term infants (n = 47; 21.2 ± 8.8 pg/mL; p = 0.034 by Mann-Whitney U test). There was no correlation between birth weight, length, head circumference, and β-NGF levels. In microcephalic children, NGF levels were low (8 pg/mL) compared with control infants' values (22 pg/mL). In adults, β-NGF levels were higher and ranged between 238 and 292 pg/mL. Our study demonstrates that β-NGF levels can be assessed in human newborn sera using a two-site enzyme immunoassay with MAb 27/21 to mouse β-NGF, that β-NGF levels are extremely low in newborns compared with adults, that β-NGF levels seems to show developmental changes, and that β-NGF levels may be used to assess NGF utilization under normal and pathologic conditions such as cerebral malformations.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Haddad, J., Vilge, V., Juif, J. et al. β-Nerve Growth Factor Levels in Newborn Cord Sera. Pediatr Res 35, 637–639 (1994). https://doi.org/10.1203/00006450-199406000-00004
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/00006450-199406000-00004
